Although a common misconception is that MS causes disability later in life. However, most people are diagnosed with MS in the prime of their life – 20s, 30s or 40s – and approximately 85 percent of people are initially diagnosed with relapsing-remitting MS, compared to 10-15 percent who have a progressive course from disease onset.
In the past 25 years, more than a dozen new treatments for MS have been approved by the FDA. They reduce the frequency/severity of relapses, reduce the accumulation of lesions in the brain and spinal cord, and slow the accumulation of disability. These treatments, combined with rehabilitation strategies, complementary and alternative approaches, and consideration for overall wellness offer professionals significant ability to participate in comprehensive care that can improve function and quality of life.
Generally speaking, patients with MS seek to build a cooperative, meaningful, long-term relationships with a multi-disciplinary comprehensive care team – to effectively manage a complex disease that spans a lifetime.